John Vavricka

John Vavricka

Corporate Officer/Principal at ATEA PHARMACEUTICALS, INC.

Net worth: 771 026 $ as of 31/05/2026

62 year
Health Technology
Consumer Services

Profile

John F.
Vavricka
was the founder of Iroko Pharmaceuticals LLC, founded in 2007, serving as President & Chief Executive Officer.
Mr. Vavricka was the founder of Biothea Pharma, Inc., founded in 2015, serving as Chief Executive Officer.
Mr. Vavricka is currently the Chief Commercial Officer at Atea Pharmaceuticals, Inc., starting in 2018.
Former positions include President & Chief Executive Officer at Iroko Pharmaceuticals, Inc., Chief Executive Officer at Iroko Holdings LLC, Vice President-Commercial Operations at Seqirus Vaccines Ltd. from 2003 to 2007, Vice President-Regional Sales at GlaxoSmithKline Pharmaceuticals Ltd. from 2001 to 2003, Vice President-Regional Sales at Smithkline Beecham Pharmaceuticals (India) Ltd. from 1987 to 1999, and Vice President-Commercial Operations at Novartis Vaccines & Diagnostics, Inc. Education includes an undergraduate degree from Northwestern University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
24/04/2026 1,65,102 ( 0.21% ) 771 026 $ 31/05/2026

John Vavricka active positions

CompaniesPositionStart
ATEA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/10/2018

Former positions of John Vavricka

CompaniesPositionEnd
Chief Executive Officer 01/06/2021
Chief Executive Officer 06/07/2016
Corporate Officer/Principal -
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Corporate Officer/Principal -
Sales & Marketing -
See the detail of John Vavricka's experience

Training of John Vavricka

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!